Marc Puigvehí (Marc Puigvehi)

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 5

Top Topics

Cell Proliferation

Cardiac Surgery

Top Venues

Molecular cancer therapeutics

Liver international : official journal of the International Association for the Study of the Liver

Hepatology (Baltimore, Md.)

Cancer discovery

This page only lists publications with an associated author ORCID identifier.

Publications

Jordi Abril-Fornaguera, Laura Torrens, Carmen Andreu-Oller, Juan Carrillo-Reixach, Alexander Rialdi, Ugne Balaseviciute, Roser Pinyol, Carla Montironi, Philipp K Haber, Álvaro Del Río-Álvarez, Montserrat Domingo-Sàbat, Laura Royo, Nicholas K Akers, Catherine E Willoughby, Judit Peix, Miguel Torres-Martin, Marc Puigvehí, Stefano Cairo, Margaret Childs, Rudolf Maibach, Rita Alaggio, Piotr Czauderna, Bruce Morland, Bojan Losic, Vincenzo Mazzaferro, Ernesto Guccione, Daniela Sia, Carolina Armengol, Josep M Llovet
Identification of IGF2 as Genomic Driver and Actionable Therapeutic Target in Hepatoblastoma. Molecular cancer therapeutics (2023)
Jordi Abril-Fornaguera, Laura Torrens, Carmen Andreu-Oller, Juan Carrillo-Reixach, Alexander Rialdi, Ugne Balaseviciute, Roser Pinyol, Carla Montironi, Philipp K Haber, Álvaro Del Río-Álvarez, Montserrat Domingo-Sàbat, Laura Royo, Nicholas K Akers, Catherine E Willoughby, Judit Peix, Miguel Torres-Martin, Marc Puigvehí, Stefano Cairo, Margaret Childs, Rudolf Maibach, Rita Alaggio, Piotr Czauderna, Bruce Morland, Bojan Losic, Vincenzo Mazzaferro, Ernesto Guccione, Daniela Sia, Carolina Armengol, Josep M Llovet
Identification of IGF2 as Genomic Driver and Actionable Therapeutic Target in Hepatoblastoma. Molecular cancer therapeutics (2023)
Laura Torrens, Carla Montironi, Marc Puigvehí, Agavni Mesropian, Jack Leslie, Philipp K Haber, Miho Maeda, Ugne Balaseviciute, Catherine E Willoughby, Jordi Abril-Fornaguera, Marta Piqué-Gili, Miguel Torres-Martin, Judit Peix, Daniel Geh, Erik Ramon-Gil, Behnam Saberi, Scott L Friedman, Derek A Mann, Daniela Sia, Josep M Llovet
Immunomodulatory Effects of Lenvatinib Plus Anti-Programmed Cell Death Protein 1 in Mice and Rationale for Patient Enrichment in Hepatocellular Carcinoma. Hepatology (Baltimore, Md.) 74 (5) (2021)
Marina Ruiz de Galarreta, Erin Bresnahan, Pedro Molina-Sánchez, Katherine E Lindblad, Barbara Maier, Daniela Sia, Marc Puigvehí, Verónica Miguela, María Casanova-Acebes, Maxime Dhainaut, Carlos Villacorta-Martin, Aatur D Singhi, Akshata Moghe, Johann von Felden, Lauren Tal Grinspan, Shuang Wang, Alice Oliffson Kamphorst, Satdarshan P Monga, Brian D Brown, Augusto Villanueva, Josep M Llovet, Miriam Merad, Amaia Lujambio
β-Catenin Activation Promotes Immune Escape and Resistance to Anti-PD-1 Therapy in Hepatocellular Carcinoma. Cancer discovery 9 (8) (2019)
Marc Puigvehí, Beatriz De Cuenca, Ana Viu, Moisés Diago, Juan Turnes, Francisco Gea, Juan M Pascasio, Sabela Lens, Joaquín Cabezas, Ester Badia, Antonio Olveira, Rosa M Morillas, Xavier Torras, Silvia Montoliu, Patricia Cordero, José L Castro, Javier Salmerón, Esther Molina, Juan J Sánchez-Ruano, Javier Moreno, María D Antón, José M Moreno, Juan De la Vega, José L Calleja, Jose Antonio Carrión
Eight weeks of Paritaprevir/r/Ombitasvir + Dasabuvir in HCV genotype 1b with mild-moderate fibrosis: Results from a real-world cohort. Liver international : official journal of the International Association for the Study of the Liver 39 (1) (2018)